Publications

ESMO open

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

01-12-2021

ESMO open

Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs.

01-12-2021

The Lancet. Oncology

Immunotherapy for cancer treatment during pregnancy.

01-12-2021

Cell reports

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8⁺ T cells.

16-11-2021

Cancer immunology, immunotherapy : CII

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.

01-11-2021

European journal of cancer (Oxford, England : 1990)

Adjuvant treatment for melanoma in clinical practice - Trial versus reality.

01-11-2021

European journal of cancer (Oxford, England : 1990)

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study.

01-11-2021

Proceedings of the National Academy of Sciences of the United States of America

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

26-10-2021

Cancers

Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.

11-10-2021

European journal of cancer (Oxford, England : 1990)

Sex-differences in symptoms and functioning in >5000 cancer survivors: Results from the PROFILES registry.

01-10-2021

Clinical cancer research : an official journal of the American Association for Cancer Research

Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.

01-10-2021

Cancers

Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.

16-09-2021

Journal of geriatric oncology

Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry.

01-09-2021

European journal of cancer (Oxford, England : 1990)

Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003-2018): A nationwide population-based study.

01-09-2021

Annals of surgery

Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.

01-08-2021

ESMO open

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II.

01-08-2021

Journal for immunotherapy of cancer

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial.

01-08-2021

The American Journal of dermatopathology

Letter Regarding Editorial by Samuel Zagarella.

01-07-2021

Journal for immunotherapy of cancer

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors.

01-07-2021

Nature medicine

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.

01-07-2021

Cancers

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy.

21-06-2021

Cancers

Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors.

05-06-2021

Clinical genitourinary cancer

Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.

01-06-2021

ESMO open

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.

01-06-2021

Annals of oncology : official journal of the European Society for Medical Oncology

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.

01-06-2021

Cancer immunology, immunotherapy : CII

Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.

01-05-2021

Annals of internal medicine

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.

01-05-2021

British journal of cancer

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF^V600-mutant advanced melanoma patients: a propensity-matched survival analysis.

01-05-2021

Hepatology international

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients.

01-04-2021

Nature medicine

COVID-19 vaccination: the VOICE for patients with cancer.

01-04-2021

ESMO open

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration.

01-04-2021

BMC cancer

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.

25-03-2021

Cancer cell

The power to "di-sc-seq-t".

08-03-2021

British journal of cancer

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF^V600-mutant advanced melanoma patients: a propensity-matched survival analysis.

01-03-2021

American journal of clinical oncology

Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.

01-02-2021

Hematology/oncology clinics of North America

Cellular Therapy and Cytokine Treatments for Melanoma.

01-02-2021

European journal of cancer (Oxford, England : 1990)

Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry.

01-02-2021

Nature medicine

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

01-02-2021

Melanoma research

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.

01-02-2021

Oncoimmunology

T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 production.

21-01-2021

Annals of the rheumatic diseases

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

01-01-2021

Journal for immunotherapy of cancer

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition.

01-01-2021

International journal of cancer

Real-world outcomes of advanced melanoma patients not represented in phase III trials.

15-12-2020

Immuno-oncology technology

IOTECH in times of COVID-19.

01-12-2020

European journal of cancer (Oxford, England : 1990)

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study.

01-12-2020

ESMO open

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease.

01-11-2020

Nature medicine

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.

01-11-2020

Annals of oncology : official journal of the European Society for Medical Oncology

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.

01-11-2020

Annals of oncology : official journal of the European Society for Medical Oncology

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.

01-11-2020

Cancer cell

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.

12-10-2020